Immunotherapy Targeting Tumor-Associated Macrophages

被引:19
作者
Liu, Yafei [1 ]
Wang, Rongsi [2 ]
机构
[1] China Med Univ, Affiliat Hosp 4, Dept Pharm, Shenyang, Peoples R China
[2] East China Normal Univ, High Sch, Shanghai, Peoples R China
关键词
macrophage; tumor microenvironment; cancer; immunotherapy; polarization; FUNCTIONAL POLARIZATION; THERAPEUTIC RESISTANCE; PANCREATIC-CANCER; SUPPRESSOR-CELLS; SIGNALING AXIS; MYELOID CELLS; ACTIVATION; METASTASIS; INHIBITION; EXPRESSION;
D O I
10.3389/fmed.2020.583708
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Macrophages are phagocytic cells that play a broad role in maintaining body homeostasis and defense against foreign pathogens; whereas tumor-associated macrophages (TAMs) support tumor growth and metastasis by promoting cancer cell proliferation and invasion, immunosuppression, and angiogenesis, which is closely related to the poor prognosis in almost all solid tumors. Hence, deep-insight knowledge into TAMs can provide an opportunity to discover more effective strategies for cancer therapeutics. So far, a large number of therapeutic agents targeting TAMs are in clinical trials. In this review, we introduce an extensive overview about macrophages and macrophage-targeting agents.
引用
收藏
页数:11
相关论文
共 132 条
[1]   Engineered immune cells as highly sensitive cancer diagnostics [J].
Aalipour, Amin ;
Chuang, Hui-Yen ;
Murty, Surya ;
D'Souza, Aloma L. ;
Park, Seung-min ;
Gulati, Gunsagar S. ;
Patel, Chirag B. ;
Beinat, Corinne ;
Simonetta, Federico ;
Martinic, Ivana ;
Gowrishankar, Gayatri ;
Robinson, Elise R. ;
Aalipour, Eamon ;
Zhian, Zahra ;
Gambhir, Sanjiv S. .
NATURE BIOTECHNOLOGY, 2019, 37 (05) :531-+
[2]   MiR-21 modulates the polarization of macrophages and increases the effects of M2 macrophages on promoting the chemoresistance of ovarian cancer [J].
An, Yuanyuan ;
Yang, Qing .
LIFE SCIENCES, 2020, 242
[3]  
[Anonymous], 2016, SCI REP UK
[4]   CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy [J].
Barkal, Amira A. ;
Brewer, Rachel E. ;
Markovic, Maxim ;
Kowarsky, Mark ;
Barkal, Sammy A. ;
Zaro, Balyn W. ;
Krishnan, Venkatesh ;
Hatakeyama, Jason ;
Dorigo, Oliver ;
Barkal, Layla J. ;
Weissman, Irving L. .
NATURE, 2019, 572 (7769) :392-+
[5]   Engagement of MHC class I by the inhibitory receptor LILRB1 suppresses macrophages and is a target of cancer immunotherapy [J].
Barkal, Amira A. ;
Weiskopf, Kipp ;
Kao, Kevin S. ;
Gordon, Sydney R. ;
Rosental, Benyamin ;
Yiu, Ying Y. ;
George, Benson M. ;
Markovic, Maxim ;
Ring, Nan G. ;
Tsai, Jonathan M. ;
McKenna, Kelly M. ;
Ho, Po Yi ;
Cheng, Robin Z. ;
Chen, James Y. ;
Barkal, Layla J. ;
Ring, Aaron M. ;
Weissman, Irving L. ;
Maute, Roy L. .
NATURE IMMUNOLOGY, 2018, 19 (01) :76-+
[6]   Deciphering human macrophage development at single-cell resolution [J].
Bian, Zhilei ;
Gong, Yandong ;
Huang, Tao ;
Lee, Christopher Z. W. ;
Bian, Lihong ;
Bai, Zhijie ;
Shi, Hui ;
Zeng, Yang ;
Liu, Chen ;
He, Jian ;
Zhou, Jie ;
Li, Xianlong ;
Li, Zongcheng ;
Ni, Yanli ;
Ma, Chunyu ;
Cui, Lei ;
Zhang, Rui ;
Chan, Jerry K. Y. ;
Ng, Lai Guan ;
Lan, Yu ;
Ginhoux, Florent ;
Liu, Bing .
NATURE, 2020, 582 (7813) :571-+
[7]   Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm [J].
Biswas, Subhra K. ;
Mantovani, Alberto .
NATURE IMMUNOLOGY, 2010, 11 (10) :889-896
[8]   Cessation of CCL2 inhibition accelerates breast cancer metastasis by promoting angiogenesis [J].
Bonapace, Laura ;
Coissieux, Marie-May ;
Wyckoff, Jeffrey ;
Mertz, Kirsten D. ;
Varga, Zsuzsanna ;
Junt, Tobias ;
Bentires-Alj, Mohamed .
NATURE, 2014, 515 (7525) :130-133
[9]   Macrophage Ontogeny Underlies Differences in Tumor-Specific Education in Brain Malignancies [J].
Bowman, Robert L. ;
Klemm, Florian ;
Akkari, Leila ;
Pyonteck, Stephanie M. ;
Sevenich, Lisa ;
Quail, Daniela F. ;
Dhara, Surajit ;
Simpson, Kenishana ;
Gardner, Eric E. ;
Iacobuzio-Donahue, Christine A. ;
Brennan, Cameron W. ;
Tabar, Viviane ;
Gutin, Philip H. ;
Joyce, Johanna A. .
CELL REPORTS, 2016, 17 (09) :2445-2459
[10]  
Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI [10.3322/caac.21609, 10.3322/caac.21492]